Supplier Spotlight® highlights the unique skill sets and service offerings of our vast supplier network. Below is an interview with Actu-Real, whose mission is to combine statistical, actuarial, data sciences, drug development and health economics expertise to enable data-driven, evidence-based… Continue Reading
The new model of access strategy should build around four key pillars, says Jeff Weisel, Senior Advisor Asia-Pacific, PRMA Consulting. In this update, Jeff explores why the shifting currents of global healthcare are dictating a new approach to market access. Continue Reading
Education Spotlight highlights the unique educational opportunities available in HEOR, Market Access, and RWE/RWD. Below is an interview with European Market Access University Diploma (EMAUD). Continue Reading
Jeff Anderson is CEO of the Evidence & Access practice and Rosemary Jose leads Strategic Market Access strategy and activities. They talk about current dynamics in the healthcare industry and the challenges of generating evidence for optimal market access. Continue Reading
The complex, costly, and continuously evolving arena of biopharmaceutical product development demands a constant eye on commercialization potential. Continue Reading
